|
Subject
|
Antibody status (RF/ACPA)
|
DAS28 0 m
|
DAS28 6 m
|
Medication after baseline sampling
|
|---|
|
1
|
+/+
|
3.89
|
3.88
|
Mtx + GC
|
|
2
|
+/+
|
4.68
|
2.58B, D
|
Mtx + GC
|
|
3
|
+/+
|
5.04
|
1.05B, D
|
Mtx + GC
|
|
4
|
+/+
|
5.70
|
3.44C
|
Mtx
|
|
5
|
+/+
|
7.39
|
2.24/2.53B, E
|
Mtx + GC
|
|
6
|
+/+
|
5.47
|
3.46C
|
Mtx
|
|
7
|
−/+
|
4.90
|
2.84A, B
|
Mtx
|
|
8
|
−/−
|
5.52
|
2.39B, D
|
Mtx + GC
|
|
9
|
+/+
|
5.49
|
1.63B, D
|
Mtx + GC
|
|
10
|
+/+
|
4.31
|
2.63A. B
|
Mtx
|
- Abbreviations: DAS28 disease activity score 28, Mtx methotrexate, GC glucocorticoids
- A low disease activity; B remission; C moderate improvement; D good improvement; E DAS28 at 6 m not available, displayed are DAS28 at 3 m/13 m
